Tirzepatide, and why two receptors change the feel of it

The dual-agonist everyone compares semaglutide against, explained in three minutes.

What it is

Tirzepatide is a single molecule that acts on two gut hormone receptors at once, GLP-1 and GIP. Semaglutide works on GLP-1 alone. That second target is the whole story behind the different appetite and blood sugar numbers people quote.

How it works

GLP-1 signalling slows how fast the stomach empties and tells the brain you have eaten enough. Adding GIP appears to improve how fat tissue handles incoming energy and may soften the nausea that comes with pushing GLP-1 alone. The two signals together tend to do more at a lower push on either one.

What people notice

Appetite quiets down within the first week, usually before the scale moves. Food noise fades. Portions that felt normal start feeling like too much. Most of the reported side effects show up in the days right after a dose step-up rather than at a steady dose.

What to watch for

Nausea, constipation, and reflux are the common complaints, and they track closely with how fast the dose climbs. Protein intake and resistance training matter here, because weight coming off fast takes muscle with it if nothing pushes back. Anyone with a personal or family history of medullary thyroid cancer or MEN2 is excluded from the trials for a reason.

One thing to remember

If the first weeks feel rough, the usual fix is time at the current dose rather than a jump to the next one.